Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A

Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A

301290 · SHE · Healthcare / Medical Devices

25.70CNY-0.47 (-1.80%)

Price History

Full chart

Market Stats

Previous Close26.17
Open26.00
Day Range25.66 – 26.44
52-Week Range21.60 – 36.72
Volume1.45M
Market Cap2.87B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.33
Dividend Yield1.05%
Beta0.69
50-Day Avg27.73
200-Day Avg28.29

About

Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacturing, and sale of surgical medical devices, staplers, and spare parts in China. It offers orthopedic traction frames, surgical lamps, hospital system integration solutions, electric gynecological examination tables, obstetrics and gynecology examination tables, electric operating tables, multi-functional intelligent operating tables, ventilators, surgical endoscopes, ultrasound equipment, hydrogen peroxide low-temperature plasma sterilizers, and multifunctional monitoring modules; medical consumables; and open stapler surgical equipment, such as linear cutting stapler, tubular stapler, and hemorrhoidal stapler. The company also provides surgical equipment, such as monitor stands, endoscope compound arm pendant, compound arm crane, dry and wet separation suspension bridges, hanging columns, electric endoscope pendant, cavity mirror hanging towers, cavity mirror pendant towers, and electric delivery beds. It also exports its products to Europe, South America, Southeast Asia, the Middle East, and Africa. The company was founded in 2001 and is based in Changzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jiangang Wei
  • Employees727
  • HeadquartersNo. 24-4, Changyang Road, Changzhou, China, 213115, China
  • Websitehttps://www.dx-med.com

Leadership

  • Mr. Jiangang WeiGM & Director · b. 1972
  • Ms. Aiqing GongCFO, Deputy GM, Board Secretary & Director · b. 1971
  • Mr. Zhengyuan WanDeputy GM & Director · b. 1988
  • Xu HailanAccounting Supervisor

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue374.43M446.50M442.10M433.73M435.46M387.49M
Growth (%)-+19.25%-0.99%-1.89%+0.40%-11.02%
Cost of Revenue166.65M190.30M210.99M224.33M220.49M199.21M
Gross Profit207.77M256.20M231.11M209.41M214.97M188.28M
Gross Margin55.49%57.38%52.28%48.28%49.37%48.59%
Operating Expense110.41M127.40M115.78M120.95M130.34M134.20M
Operating Income97.37M128.80M115.33M88.46M84.63M54.08M
Operating Margin26.00%28.85%26.09%20.39%19.44%13.96%
EBITDA--156.32M156.48M158.13M15.71M
EBITDA Margin--35.36%36.08%36.31%4.05%
Net Income79.70M110.25M102.51M97.22M97.42M-37.94M
Net Income Margin21.29%24.69%23.19%22.42%22.37%-9.79%
R&D18.32M20.67M24.21M27.11M22.43M20.97M
R&D as % of Total Revenue4.89%4.63%5.48%6.25%5.15%5.41%
Interest Expense2.30M111.39K133.93K63.09K338.53K1.27M
Interest Expense % of Total Revenue0.62%0.02%0.03%0.01%0.08%0.33%

Balance Sheet

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.14B1.24B2.38B2.39B2.48B2.43B
Total Liabilities156.79M146.95M180.04M147.37M228.88M274.04M
Total Equity975.90M1.09B2.19B2.24B2.25B2.15B
Cash121.54M138.46M1.11B568.86M295.18M78.41M
Net Debt-----37.51M

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow114.07M163.45M94.63M163.13M126.49M84.09M
Capital Expenditure25.43M95.67M74.35M111.46M115.96M46.06M
Free Cash Flow88.64M67.78M20.28M51.68M10.54M38.03M
Dividends Paid2.30M--50.09M59.59M60.42M
FCF to OCF77.71%41.47%21.43%31.68%8.33%45.22%
Dividend Paid to FCF2.60%--96.93%565.61%158.89%

Earnings

Report DateDec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------
EPS Actual0.250.180.320.210.260.200.280.180.320.120.18-0.850.150.180.16
Surprise---------------
Timing---------------

Key Statistics & Ratios

Market Cap2.87B
Enterprise Value1.85B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.48
Price / Book1.39
EPS-0.33
Book Value21.81
Revenue (TTM)384.50M
Gross Profit (TTM)187.18M
EBITDA90.21M
Profit Margin-8.87%
Operating Margin8.10%
Return on Equity-1.65%
Return on Assets1.28%
Shares Outstanding100.17M
Shares Float58.26M
Beta0.69
Dividend Yield1.05%
Dividend Rate0.30
Payout Ratio75.00%

Dividends

20261×
0.30Jun 10, 2026
20251×
0.60May 15, 2025
20241×
0.60Jun 13, 2024
20231×
0.50May 26, 2023